Ajanta Pharma re-appoints Madhusudan B Agrawal as Vice Chairman, Executive Director

Published On 2025-05-01 10:45 GMT   |   Update On 2025-05-01 10:45 GMT
Advertisement

MumbaiAjanta Pharma has announced the re-appointment of Madhusudan B. Agrawal as Vice Chairman and Executive Director for a term of 5 years w.e.f 1st April 2025.

In a recent BSE filing, the Company stated," At the Board meeting held on Wednesday, 30th April 2025, Board has approved the re-appointment of Madhusudan B. Agrawal (DIN: 00073872) as Executive Director and Vice Chairman for a term of 5 years w.e.f 1st April 2025, subject to approval of members of the Company."

Advertisement

Madhusudan Agrawal has rich experience of over 47 years in the industry. His core competencies include corporate affairs, business development, business acumen, vision, industry knowledge, international business, general management, leadership, people management, networking, public relation, etc. He contributes effectively towards social causes and philanthropic activities of the company.

Agrawal currently serves as the Honorary Consul of Uganda in Mumbai, India (Western Zone). In addition, he holds the positions of the General Secretary of Honorary Consular Corps Diplomatique-India (HCCD) Mumbai and the Director of HCCD India. 

His work in business, diplomacy, and philanthropy has been recognized with multiple prestigious honours. Last month, he received 'Consular of the Year' award from HCCD. Among his other notable honours are the Golden Jubilee Medal - the Highest Civilian Award - Conferred by President of Uganda Yoweri Museveni, the ABLF Business Innovator Award, presented by the Asian Business Leadership Forum in Dubai, the Seva Bhushan Samman from the Governor of Uttarakhand. He was also honored with the Icons of Aurangabad Award, recognized by industrialist Ratan Tata.

Read also: Ajanta Pharma Vice Chairman Madhusudan Agrawal honoured with 'Consular of the Year' award

Ajanta Pharma is a speciality pharmaceutical formulation company having major focus on branded generic business across India, Asia & Africa. The company has a ground presence in each of these 30+ countries.

The company’s state-of-the-art R&D centre is located in Mumbai. The company has 7 world-class manufacturing facilities located in India.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News